Pediatrix Medical (MD) Capital Expenditures (2009 - 2026)

Pediatrix Medical (MD) has reported Capital Expenditures for 18 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 127.85% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was -$4.6 million, a 82.67% increase from a year earlier, with the FY2025 full-year figure at -$21.8 million, up 35.37% from the prior year.
• Capital Expenditures was $1.4 million for Q2 2026 at Pediatrix Medical, down from $6.2 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $9.2 million in Q3 2023 and troughed at -$13.6 million in Q3 2024.
• A 5-year average of $840888.9 and a median of $3.8 million in 2026 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures sank 248.72% in 2024 and surged 234.37% in 2026, its largest moves.
• Over 5 years, Capital Expenditures stood at $9.1 million in 2022, then fell by 0.15% to $9.0 million in 2023, then plunged by 134.93% to -$3.2 million in 2024, then plunged by 52.77% to -$4.8 million in 2025, then soared by 128.57% to $1.4 million in 2026.
• The last three Capital Expenditures figures came in at $1.4 million (Q2 2026), $6.2 million (Q1 2026), and -$4.8 million (Q4 2025), per Business Quant data.